• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Australia·Basic Materials·HRE.AX
Share

Heavy Rare Earths Limited Stocks

A$ 0.04Last Updated 19.10.2026

Issuer Rating

1/7
Performance

Poor

Risk

High

Recommendation

Sell

Market Cap

A$ 4.63M

A$ 0.04
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Heavy Rare Earths Limited is an enterprise primarily focused on the discovery and development of rare earth mineral resources, conducting its exploration activities across Western Australia and the Northern Territory. The company possesses an exclusive option to acquire the Cowalinya project, an exploration zone extending over 230 square kilometers, situated southeast of Norseman in Western Australia. Additionally, it maintains complete ownership of the Duke project, encompassing two exploration licenses that cover a combined area of 255 square kilometers, located northwest of Tennant Creek in the Northern Territory. This firm was established in 2021 and its corporate headquarters are located in Melbourne, Australia.

Company Valuation

Greatly overvalued
1/7

From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

20.10.2026 21:47

"A Roller-Coaster Ride for Stocks": What Wall Street Is Saying Ahead of SpaceX's Earnings Report

20.10.2026 20:36

Why Cathie Wood's team expects Tesla's stock to rise by more than 1,000%

20.10.2026 20:11

"A Vicious Cycle": What Risks Does Rising Bond Yields Pose to the Stock Market?

20.10.2026 19:39

"The Weak Link": The risk premium on French government bonds has approached a 15-year high

20.10.2026 19:05

Veradermics jumps on successful hair-loss pill trial. Is the stock a buy?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026